The Regen® ATS tube facilitates rapid preparation of an Autologous Thrombin Serum at point-of-care, simultaneous to the preparation of Leukocyte-Poor A-PRP® (RegenPlasma®) utilizing Regen® BCT.
The combination of Regen® BCT and Regen® ATS offers a host of possibilities. With the addition of autologous thrombin serum to a liquid PRP, a platelet-rich fibrin gel can be achieved.
Should a provider feel it is necessary, ratio may be adjusted at their discretion, such that platelet-rich gels of varying strengths and rigidity may be achieved.
In this way, a provider can make their expert determination regarding how best to meet their patient’s individual needs, achieving the optimal state and shape for the respective situation.
The result is a feat of tissue engineering: prepared at point of care and fully biocompatible with the patient from which the blood was drawn, which can also be used as a dimensionally stable membrane if required.
Intended Use of the Device: All models of RegenKit®-BCT Plus are designed to be used for the safe and rapid preparation of autologous platelet-rich plasma (PRP) and autologous serum from a small sample of blood at the patient’s point of care. The combined PRP and autologous serum are mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.
The RegenKit®-BCT Plus Family Kits are for single use only.
RegenKit BCT-2 Plus has the capability to prepare a fully autologous platelet-rich gel from a 30 mL Blood Draw, 2 x 10 mL tubes for PRP preparation, and the third 10 mL tube for preparation of autologous thrombin serum. Each Regen® BCT tube generates roughly 5-6 mL of RegenPlasma® | Leukocyte-Poor A-PRP®.
Platelet-Rich Gel Explanation: The addition of autologous thrombin serum (ATS) to the RegenPRP™ begins the coagulation process on a physiological level. Autologous Thrombin Serum (ATS) converts soluble fibrinogen into fibrin monomers, which polymerize into a clot.
This natural process induces the formation of a three-dimensional fibrin matrix in which the platelets are embedded. This enables long-lasting growth factor delivery at the treatment site and the matrix serves as a scaffold for new tissue reconstruction.
The coagulation process is a complex cascade of reactions that causes the thrombin to convert soluble fibrinogen into insoluble fibrin molecules that form the fibrin clot. If calcium is added, this accelerates the process and the fibrin structure is strengthened.
simple, safe and efficient point-of-care preparation of autologous platelet-rich plasma
Available in both 10 mL and 20 mL Kits.
Regen® Innovative Preparation methods, combined with the “GMP Lab in a Tube” and the Regen® A-PRP® Cellular Selectivity Model, facilitate an efficient and consistent preparation which allows a provider to choose the preparation which best fits their individual patient’s needs.